Akebia Therapeutics, Inc.AKBANASDAQ
Loading
Year-over-year revenue growth rate
Percentile
P33
Within normal range
vs 3Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -1.95% |
| Q3 2025 | -5.93% |
| Q2 2025 | 8.96% |
| Q1 2025 | 23.31% |
| Q4 2024 | 24.23% |
| Q3 2024 | -14.25% |
| Q2 2024 | 33.86% |
| Q1 2024 | -41.98% |
| Q4 2023 | 33.65% |
| Q3 2023 | -25.42% |
| Q2 2023 | 40.92% |
| Q1 2023 | -27.50% |
| Q4 2022 | 13.27% |
| Q3 2022 | -61.45% |
| Q2 2022 | 104.81% |
| Q1 2022 | 6.97% |
| Q4 2021 | 18.30% |
| Q3 2021 | -7.86% |
| Q2 2021 | 1.16% |
| Q1 2021 | -7.75% |
| Q4 2020 | -5.48% |
| Q3 2020 | -33.45% |
| Q2 2020 | 1.88% |
| Q1 2020 | 27.21% |
| Q4 2019 | -24.38% |
| Q3 2019 | -8.76% |
| Q2 2019 | 38.72% |
| Q1 2019 | 21.41% |
| Q4 2018 | 12.57% |
| Q3 2018 | 8.97% |
| Q2 2018 | 6.23% |
| Q1 2018 | -47.40% |
| Q4 2017 | 111.51% |
| Q3 2017 | 44.75% |
| Q2 2017 | 36.69% |
| Q1 2017 | 1259.28% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |